Tip-flexible suctioning ureteral access sheath combined with flexible ureteroscope: a single-institution experience including in vitro experiments

尖端可弯曲的吸液式输尿管鞘联合软性输尿管镜:单中心经验及体外实验

阅读:2

Abstract

BACKGROUND: To evaluate the clinical application value of tip-flexible suctioning ureteral access sheath (TFS-UAS), this study compares the efficacy and safety of TFS-UAS versus traditional ureteral access sheath (T-UAS) in treating unilateral renal or proximal ureteral calculi, and further summarizes the usage strategy of TFS-UAS by synthesizing vitro experiment and surgical best practices. METHODS: A retrospective analysis was conducted on 196 patients with renal or proximal ureteral calculi treated with FURS and holmium laser lithotripsy at Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Patients were divided into TFS-UAS and T-UAS groups. Primary data included operative time, immediate SFR (iSFR), and 2-week SFR. Secondary data encompassed changes in blood parameters (leukocytes, hemoglobin, urea nitrogen, creatinine), complications, and hospital stay. RESULTS: This retrospective study found that urologists preferred to use TFS-UAS for larger (17.73 ± 7.79 mm vs. 12.56 ± 5.14 mm, P < 0.001), harder (1156.52 ± 420.15 vs. 778.39 ± 513.46 Hounsfield units, P < 0.001), and more complex (modified STONE score: 10.86 ± 2.51 vs. 7.37 ± 2.28, P < 0.001) upper urinary tract calculi. No significant differences in operative time or SFR were found between the TFS-UAS and T-UAS groups overall. However, for stones ≥ 15 mm, those that were larger(22.57 ± 6.35 mm vs. 18.70 ± 3.82 mm, P = 0.001), harder(1160.76 ± 382.84 vs. 896.56 ± 465.33, P = 0.007), and more complex(modified STONE score: 11.43 ± 2.40 vs. 8.63 ± 2.31, P < 0.001), TFS-UAS significantly reduced operative time (53.92 ± 21.77 vs. 65.76 ± 22.43 min, P < 0.001) and improved iSFR(91.89% vs. 73.17%, P = 0.063), 2-week SFR(81.08% vs. 56.10%, P = 0.018). CONCLUSIONS: TFS-UAS combined with FURS significantly improves operative efficiency and SFRs for upper urinary tract calculi ≥ 15 mm, demonstrating clinical advantages.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。